Road Closures Near 801 Broadway Parking Garage
News & Updates
Find A Specialist
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Rajneesh Mahajan, M.D.
Kennedy Krieger Institute
707 N. Broadway
Baltimore, MD 21205
Psychiatry Clinic Nurse Line: (443) 923-9493
CARD Nurse Line: (443) 923-7646
Dr. Rajneesh Mahajan is a child and adolescent psychiatrist who is on the faculty of the Department of Psychiatry at the Kennedy Krieger Institute and at the Johns Hopkins University School of Medicine.
Dr. Rajneesh Mahajan received his medical degree from Maulana Azad Medical College (University of Delhi), in 1992. After some training in psychiatry in India, he interned in general psychiatry at the Medical College of Virginia Hospital in Richmond, Virginia. He then moved to Baltimore, Maryland and graduated from the general psychiatry residency training program at the University of Maryland Medical Center in 1999. He received his training in child and adolescent psychiatry from the combined University of Maryland/Sheppard Pratt Hospital program in Baltimore, Maryland, graduating in 2001. He is board-certified in both general psychiatry and in child and adolescent psychiatry.
After having worked as a child and adolescent psychiatrist in both outpatient and acute inpatient settings, he moved to the Kennedy Krieger Institute because of his interest in autism spectrum disorders (ASD) in January 2007. At Kennedy Krieger, he has worked at the Kennedy Krieger school and the outpatient psychiatry clinic. He has been providing diagnostic evaluation services and psychopharmacological treatments at the Center for Autism and Related Disorders (CARD) since January 2008. In addition, he also provides consultation to the clinical staff at the LEAP Program, a unique educational program for students with autism.
Dr. Mahajan is interested in all aspects of ASD, including the diagnosis and differential diagnoses, in the psychiatric comorbidities and their psychopharmacological treatments. In addition, he is interested in genetic and metabolic disorders that present with autistic features, offering a window into the underlying mechanisms for the development of the ASD.